Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study Group.

@article{Hiddemann1998MantlecellLH,
  title={Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study Group.},
  author={Wolfgang Hiddemann and Michael Unterhalt and Richard Herrmann and H. H. W{\"o}ltjen and Ernst D. Kreuser and Lorenz H. Tr{\"u}mper and Monika Reuss-Borst and E Terhardt-Kasten and Mirjam Busch and Andreas Neubauer and Ulrich Kaiser and R D Hanrath and H Middeke and G. W. van der Helm and Mathias Freund and Harald Von Stein and Markus Tiemann and Reza M. Parwaresch},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={1998},
  volume={16 5},
  pages={1922-30}
}
PURPOSE To compare mantle-cell lymphomas (MCLs) and follicle-center lymphomas (FCLs) for their features of clinical presentation, response to chemotherapy, and prognosis on the basis of a prospective randomized clinical trial. PATIENTS AND METHODS Patients with MCL and FCL who entered onto the prospective randomized comparison of cyclophosphamide, vincristine, and prednisone (COP) versus prednimustine and mitoxantrone (PmM) followed by a second randomization for interferon (IFN) maintenance… CONTINUE READING
35 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 35 extracted citations

Similar Papers

Loading similar papers…